Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10051599HBVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30002905HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30002906HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30082598HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30081552HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30084269HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30046771HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS30046772HIVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20004433HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20015710HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TCGA Plot Options
Drug Information
GeneBCL2
DrugBank IDDB05103
Drug NameAN-9
Target IDBE0000246
UniProt IDP10415
Regulation Typedownregulator
PubMed IDs11380606
CitationsRabizadeh E, Bairey O, Aviram A, Ben-Dror I, Shaklai M, Zimra Y: Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient. Eur J Haematol. 2001 Apr;66(4):263-71. doi: 10.1034/j.1600-0609.2001.066004263.x.
GroupsInvestigational
Direct ClassificationFatty acid esters
SMILESCCCC(=O)OCOC(=O)C(C)(C)C
Pathways
PharmGKB
ChEMBLCHEMBL100014